CClinicalTrials.gg
CompletedNCT05485662Updated Apr 12, 2024Results posted

Remineralization of Molar Incisor Hypomineralization (MIH) With a Hydroxyapatite Toothpaste

An interventional study of Hydroxyapatite toothpaste and Sodium Fluoride Toothpaste in Molar Incisor Hypomineralization, sponsored by The University of Texas Health Science Center at San Antonio. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-12.

Sponsored by The University of Texas Health Science Center at San Antonio · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study tests the remineralization of donor teeth (donorMIH) in situ in participants using 10% hydroxyapatite (HAP) toothpaste and sodium fluoride toothpaste.

Read the detailed description

Prior to each 2-week treatment phase, subjects will complete a 1-week washout period. Following the washout period, the intra-oral appliance containing a donorMIH tooth block will be fitted to each subject by a qualified dentist. Immediately after fitting of the first appliance (on day 1 of the first treatment phase), each subject will receive a soft bristled manual toothbrush for use throughout the duration of the study and a toothpaste according to the treatment phase. Subjects will be instructed to brush their teeth with the appliance in the mouth, two times daily, for 3 minutes on each brushing episode, in the morning after breakfast and last thing before bed, then rinsing with 10 ml of water. Over the study period, all subjects will maintain their normal dietary habits.

A 7-day washout period without an appliance will follow. After completion of the second washout period, subjects will return to the clinic, and the appliance, with another MIH-bearing tooth blocks mounted, will be fitted to the subject for the phase 2 treatment period. This procedure will then be repeated until the 2-week treatment phase is completed, and each subject has gone through the two arms of the study.

02

Conditions studied

  • Molar Incisor Hypomineralization

Keywords

  • Remineralization
  • Hydroxyapatite
  • Sodium fluoride
03

In context

Molar Hypomineralization

121 studies on the registry are indexed under Molar Hypomineralization; 41 are open to participants now.

This study's enrollment of 15 is below the median of 52 across 94 interventional studies indexed under Molar Hypomineralization.

Browse Molar Hypomineralization studies →

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 435 studies on the registry; 88 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 31 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-60 years of age
  • Good general health
  • No known history of allergy to personal care/consumer products
  • Minimum of 20 natural uncrowned teeth (excluding third molars)
  • Normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥0.2 ml/min respectively
  • Able to consent
  • Availability throughout entire study
  • Willing to wear intra-oral appliance 24 hours per day
  • Willing to use only assigned products for oral hygiene for duration of study

Exclusion criteria

Exclusion Criteria:

  • Advanced periodontal disease
  • A medical condition that requires pre-medication prior to dental visits/procedures
  • Impaired salivary function
  • Orthodontic retainer(s)
  • Too few teeth to secure the oral appliance
  • Disease of the soft or hard oral tissues
  • Use of drugs that can affect salivary flow
  • Use of antibiotics one month prior to or during this study
  • Participation in another clinical study one week prior to the start of washout period or during this study period
  • Allergic hisotry to common toothpaste ingredients
  • Compromised immune system (HIV, AIDS, Immunosuppressive drug therapy)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
15 participants (actual)

Study arms

  • Other
    MIH-bearing tooth block exposed to HAP toothpaste

    A block of molar incisor hypomineralization (MIH) is mounted in an oral appliance and fitted in the subject for testing with the HAP toothpaste

    Other: Hydroxyapatite toothpaste

  • Other
    MIH-bearing block exposed to Sodium Fluoride toothpaste

    A block of molar incisor hypomineralization (MIH) is mounted in an oral appliance and fitted in the subject for testing with the sodium fluoride toothpaste

    Other: Sodium Fluoride Toothpaste

Interventions

  • OtherHydroxyapatite toothpaste

    10% Hydroxyapatite toothpaste

    Also known as: HAP toothpaste

  • OtherSodium Fluoride Toothpaste

    1450 parts per million sodium fluoride toothpaste

    Also known as: NaF toothpaste

06

What researchers measure

Primary outcomes

  1. Change in Mineral Density (MD) of Tooth

    Images will be collected from the samples to measure the mineral density before and after remineralization treatment. Total number of subjects enrolled in either the first allocation or the second allocation after the washout are included.

    Time frame: Baseline to 2 weeks

07

Results

Posted Jan 12, 2024

Participant flow

Subjects were consented and assessed for eligibility prior to inclusion into the study, and included adults over 18 years of age. Subjects were originally assigned to one of the toothpastes, then after using that toothpaste for 2 weeks, they were assigned to the other toothpaste.

Phase 1 Allocation
Participant flow — Phase 1 Allocation
MilestoneMIH-bearing Tooth Block Exposed to HAP Toothpaste Then Sodium Fluoride ToothpasteMIH-bearing Block Exposed to Sodium Fluoride Toothpaste Then the HAP Toothpaste
Started87
Completed87
Not completed00
Washout Period
Participant flow — Washout Period
MilestoneMIH-bearing Tooth Block Exposed to HAP Toothpaste Then Sodium Fluoride ToothpasteMIH-bearing Block Exposed to Sodium Fluoride Toothpaste Then the HAP Toothpaste
Started87
Completed87
Not completed00
Phase 2 Allocation
Participant flow — Phase 2 Allocation
MilestoneMIH-bearing Tooth Block Exposed to HAP Toothpaste Then Sodium Fluoride ToothpasteMIH-bearing Block Exposed to Sodium Fluoride Toothpaste Then the HAP Toothpaste
Started78
Completed78
Not completed00

Outcome measures

PrimaryChange in Mineral Density (MD) of Tooth

Images will be collected from the samples to measure the mineral density before and after remineralization treatment. Total number of subjects enrolled in either the first allocation or the second allocation after the washout are included.

Time frame:
Baseline to 2 weeks
Reported as:
Mean · percentage of remineralization
Change in Mineral Density (MD) of Tooth
percentage of remineralizationMIH-bearing Tooth Block Exposed to HAP ToothpasteMIH-bearing Block Exposed to Sodium Fluoride Toothpaste
Combined data26.02 ± 20.6814.64 ± 9.60
Etched29.26 ± 22.9916.83 ± 9.97
Unetched16.62 ± 5.7410.62 ± 8.13

Adverse events

Collected over From baseline to study end at 2 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
MIH-bearing Tooth Block Exposed to HAP Toothpaste0/8 (0%)0/8 (0%)0/8 (0%)
MIH-bearing Block Exposed to Sodium Fluoride Toothpaste0/7 (0%)0/7 (0%)0/7 (0%)
Most frequent other events
Most frequent other events
EventMIH-bearing Tooth Block Exposed to HAP ToothpasteMIH-bearing Block Exposed to Sodium Fluoride Toothpaste
BurningGastrointestinal disorders——

Baseline characteristics

Age, Continuous
Age, Continuous(years)Overall Study Enrollment
Mean50.2 (25 to 67)
Sex: Female, Male
Sex: Female, Male(Participants)Overall Study Enrollment
Female14
Male1
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Overall Study Enrollment
Hispanic or Latino10
Not Hispanic or Latino5
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Overall Study Enrollment
United States15
08

Study locations

1 site
  • School of Dentistry, University of Texas Health Science Center
    San Antonio, Texas 78229, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 5, 2022

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05485662
Lead sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Dr. Kurt Wolff GmbH & Co. KG
Responsible party
Sponsor
First posted
Aug 3, 2022
Start date
Sep 6, 2022
Primary completion
Dec 9, 2022
Completion
Dec 9, 2022
Results posted
Jan 12, 2024
Last update
Apr 12, 2024

Study contacts

Bennett T Amaechi, BDS, MS, PhD
principal investigator · University of Texas Health Science Center San Antonio

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion